31-05-2025
Morgan Stanley Sticks to Their Buy Rating for YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H (1558)
Morgan Stanley analyst Laurence Tam maintained a Buy rating on YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H (1558 – Research Report) yesterday and set a price target of HK$14.00.
Confident Investing Starts Here:
Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
According to TipRanks, Tam is a 2-star analyst with an average return of 1.5% and a 56.25% success rate.
Currently, the analyst consensus on YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H is a Moderate Buy with an average price target of HK$14.00.
The company has a one-year high of HK$15.54 and a one-year low of HK$7.92. Currently, YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H has an average volume of 6.91M.
